SG11201509503QA - 2-phenylimidazo[1,2-a]pyrimidines as imaging agents - Google Patents
2-phenylimidazo[1,2-a]pyrimidines as imaging agentsInfo
- Publication number
- SG11201509503QA SG11201509503QA SG11201509503QA SG11201509503QA SG11201509503QA SG 11201509503Q A SG11201509503Q A SG 11201509503QA SG 11201509503Q A SG11201509503Q A SG 11201509503QA SG 11201509503Q A SG11201509503Q A SG 11201509503QA SG 11201509503Q A SG11201509503Q A SG 11201509503QA
- Authority
- SG
- Singapore
- Prior art keywords
- phenylimidazo
- pyrimidines
- imaging agents
- imaging
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13168830 | 2013-05-23 | ||
| PCT/EP2014/060203 WO2014187762A1 (en) | 2013-05-23 | 2014-05-19 | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201509503QA true SG11201509503QA (en) | 2015-12-30 |
Family
ID=48446195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201509503QA SG11201509503QA (en) | 2013-05-23 | 2014-05-19 | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9801961B2 (en) |
| EP (1) | EP2999701B1 (en) |
| JP (1) | JP6130055B2 (en) |
| KR (1) | KR101770494B1 (en) |
| CN (1) | CN105229009B (en) |
| AR (1) | AR096371A1 (en) |
| AU (1) | AU2014270524B2 (en) |
| BR (1) | BR112015025140A2 (en) |
| CA (1) | CA2907605A1 (en) |
| DK (1) | DK2999701T3 (en) |
| ES (1) | ES2629389T3 (en) |
| HK (1) | HK1213558A1 (en) |
| HU (1) | HUE033612T2 (en) |
| MX (1) | MX2015015893A (en) |
| PL (1) | PL2999701T3 (en) |
| RU (1) | RU2665580C2 (en) |
| SG (1) | SG11201509503QA (en) |
| SI (1) | SI2999701T1 (en) |
| TW (1) | TW201500360A (en) |
| WO (1) | WO2014187762A1 (en) |
| ZA (1) | ZA201506570B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6730309B2 (en) | 2015-04-08 | 2020-07-29 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | Fused Bicyclic Heterocycle Derivatives and Intermediate Products as Pest Control Agents |
| EP3331870B1 (en) | 2015-08-07 | 2021-06-16 | Bayer CropScience Aktiengesellschaft | 2-(het)aryl-substituted condensed heterocycle derivatives as pesticides |
| WO2017058503A1 (en) * | 2015-09-29 | 2017-04-06 | Oncotherapy Science, Inc. | Bicyclic compound and use thereof for inhibiting suv39h2 |
| CA3002888A1 (en) | 2015-10-26 | 2017-05-04 | Bayer Cropscience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pest control agents |
| WO2017093180A1 (en) | 2015-12-01 | 2017-06-08 | Bayer Cropscience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pest control agents |
| CN105582168A (en) * | 2016-01-08 | 2016-05-18 | 王明强 | Traditional Chinese medicine preparation for treating valetudinarianism, insufficiency of primordial qi and low immunity |
| WO2017144341A1 (en) | 2016-02-23 | 2017-08-31 | Bayer Cropscience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pest control agents |
| WO2017174414A1 (en) | 2016-04-05 | 2017-10-12 | Bayer Cropscience Aktiengesellschaft | Naphthaline-derivatives as pest control agents |
| EP3241830A1 (en) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Condensed bicyclic heterocyclic derivatives as pesticides |
| AU2017298972B2 (en) | 2016-07-19 | 2021-03-04 | Bayer Cropscience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pest control agents |
| WO2018015546A1 (en) | 2016-07-22 | 2018-01-25 | Ac Immune S.A. | Compounds for imaging tau protein aggregates |
| SG11201811311VA (en) | 2016-07-22 | 2019-01-30 | Ac Immune Sa | Compounds for imaging tau protein aggregates |
| EP3497102B1 (en) | 2016-08-15 | 2022-12-07 | Bayer CropScience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pesticides |
| JP7165126B2 (en) | 2016-09-19 | 2022-11-02 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | Pyrazolo[1,5-a]pyridine derivatives and their use as pesticides |
| WO2018065288A1 (en) | 2016-10-07 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-[2-phenyl-1-(sulfonyl-methyl)-vinyl]-imidazo-[4,5-b] pyridine derivatives and related compounds as pesticides in plant protection |
| CN110312718B (en) | 2017-01-10 | 2023-02-28 | 拜耳公司 | Heterocyclene derivatives as pest control agents |
| MX2019008229A (en) | 2017-01-10 | 2019-10-24 | Bayer Ag | Heterocyclene derivatives as pest control agents. |
| WO2018138050A1 (en) | 2017-01-26 | 2018-08-02 | Bayer Aktiengesellschaft | Condensed bicyclic heterocyclene derivatives as pest control agents |
| AU2018257372B2 (en) | 2017-04-24 | 2022-06-02 | Bayer Aktiengesellschaft | Condensed bicyclic heterocyclic-compound derivatives as pest control agents |
| JP6831802B2 (en) * | 2018-01-12 | 2021-02-17 | 上海富吉医療器械有限公司Ｓｈａｎｇｈａｉ Ｃｈａｒｔｗｅｌｌ Ｍｅｄｉｃａｌ Ｉｎｓｔｒｕｍｅｎｔ Ｃｏ．， Ｌｔｄ． | Radionuclide-labeled compound and imaging agent containing it |
| EP3305786A3 (en) | 2018-01-22 | 2018-07-25 | Bayer CropScience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pesticides |
| US11306089B2 (en) | 2018-01-24 | 2022-04-19 | Life Molecular Imaging Limited | Gamma-carboline compounds for the detection of Tau aggregates |
| US20210041447A1 (en) | 2018-01-24 | 2021-02-11 | Ac Immune Sa | Azacarboline compounds for the detection of tau aggregates |
| ES2906077T3 (en) | 2018-02-21 | 2022-04-13 | Bayer Ag | Fused bicyclic heterocycle derivatives as pesticides |
| US20210252175A1 (en) * | 2018-06-08 | 2021-08-19 | Ac Immune Sa | Novel compounds for diagnosis |
| CN113727983A (en) | 2019-02-26 | 2021-11-30 | 拜耳公司 | Fused bicyclic heterocyclic derivatives as pest control agents |
| EP3931193A1 (en) | 2019-02-26 | 2022-01-05 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
| CN114890955A (en) * | 2022-06-23 | 2022-08-12 | 江西瑞威尔生物科技有限公司 | Preparation process of N-substituted morpholine organic compound |
| US20240101563A1 (en) * | 2022-07-28 | 2024-03-28 | Ac Immune Sa | Novel compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610697B1 (en) * | 1999-11-10 | 2003-08-26 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods |
| CA2410037C (en) * | 2000-05-24 | 2009-11-03 | Merck Sharp & Dohme Limited | 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors |
| CA2617319A1 (en) | 2005-06-24 | 2007-01-04 | The Trustees Of The University Of Pennsylvania | Radiolabeled-pegylation of ligands for use as imaging agents |
| US20080219922A1 (en) | 2005-09-12 | 2008-09-11 | Goodman Mark M | Alzheimer's Disease Imaging Agents |
| WO2007034282A2 (en) * | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists |
| JP4738419B2 (en) * | 2005-11-30 | 2011-08-03 | 富士フイルムＲｉファーマ株式会社 | Diagnostic and therapeutic agents for diseases caused by amyloid aggregation and / or deposition |
| EP2023919A4 (en) * | 2006-05-08 | 2010-12-22 | Molecular Neuroimaging Llc | Compounds and amyloid probes thereof for therapeutic and imaging uses |
| AU2007252658B2 (en) | 2006-05-19 | 2012-03-29 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
| US8691187B2 (en) * | 2009-03-23 | 2014-04-08 | Eli Lilly And Company | Imaging agents for detecting neurological disorders |
| US8410117B2 (en) * | 2010-03-26 | 2013-04-02 | Hoffmann-La Roche Inc. | Imidazopyrimidine derivatives |
| KR20160003173A (en) * | 2013-04-29 | 2016-01-08 | 에프. 호프만-라 로슈 아게 | 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES |
-
2014
- 2014-05-19 BR BR112015025140A patent/BR112015025140A2/en not_active Application Discontinuation
- 2014-05-19 PL PL14724757T patent/PL2999701T3/en unknown
- 2014-05-19 EP EP14724757.1A patent/EP2999701B1/en active Active
- 2014-05-19 RU RU2015149528A patent/RU2665580C2/en not_active IP Right Cessation
- 2014-05-19 CA CA2907605A patent/CA2907605A1/en not_active Abandoned
- 2014-05-19 MX MX2015015893A patent/MX2015015893A/en unknown
- 2014-05-19 KR KR1020157033039A patent/KR101770494B1/en active IP Right Grant
- 2014-05-19 DK DK14724757.1T patent/DK2999701T3/en active
- 2014-05-19 WO PCT/EP2014/060203 patent/WO2014187762A1/en active Application Filing
- 2014-05-19 AU AU2014270524A patent/AU2014270524B2/en not_active Ceased
- 2014-05-19 CN CN201480029084.XA patent/CN105229009B/en active Active
- 2014-05-19 SI SI201430251T patent/SI2999701T1/en unknown
- 2014-05-19 SG SG11201509503QA patent/SG11201509503QA/en unknown
- 2014-05-19 ES ES14724757.1T patent/ES2629389T3/en active Active
- 2014-05-19 JP JP2016514351A patent/JP6130055B2/en active Active
- 2014-05-19 HU HUE14724757A patent/HUE033612T2/en unknown
- 2014-05-20 TW TW103117655A patent/TW201500360A/en unknown
- 2014-05-21 AR ARP140102015A patent/AR096371A1/en unknown
-
2015
- 2015-09-07 ZA ZA2015/06570A patent/ZA201506570B/en unknown
- 2015-11-19 US US14/945,969 patent/US9801961B2/en active Active
-
2016
- 2016-02-11 HK HK16101490.5A patent/HK1213558A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE033612T2 (en) | 2017-12-28 |
| HK1213558A1 (en) | 2016-07-08 |
| KR101770494B1 (en) | 2017-08-22 |
| CN105229009A (en) | 2016-01-06 |
| AU2014270524A1 (en) | 2015-09-17 |
| CA2907605A1 (en) | 2014-11-27 |
| RU2665580C2 (en) | 2018-08-31 |
| EP2999701B1 (en) | 2017-04-12 |
| WO2014187762A1 (en) | 2014-11-27 |
| MX2015015893A (en) | 2016-03-04 |
| KR20150144796A (en) | 2015-12-28 |
| JP2016520091A (en) | 2016-07-11 |
| DK2999701T3 (en) | 2017-07-10 |
| US20170128598A1 (en) | 2017-05-11 |
| RU2015149528A3 (en) | 2018-03-22 |
| PL2999701T3 (en) | 2017-09-29 |
| RU2015149528A (en) | 2017-06-28 |
| ES2629389T3 (en) | 2017-08-09 |
| CN105229009B (en) | 2017-09-29 |
| JP6130055B2 (en) | 2017-05-17 |
| AR096371A1 (en) | 2015-12-23 |
| SI2999701T1 (en) | 2017-08-31 |
| EP2999701A1 (en) | 2016-03-30 |
| AU2014270524B2 (en) | 2018-01-04 |
| TW201500360A (en) | 2015-01-01 |
| AU2014270524A8 (en) | 2015-09-24 |
| ZA201506570B (en) | 2017-02-22 |
| US9801961B2 (en) | 2017-10-31 |
| BR112015025140A2 (en) | 2017-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201506570B (en) | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents | |
| HK1245764A1 (en) | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds | |
| HRP20190361T1 (en) | Triazolo[4,5-d]pyrimidine derivatives as cb2 receptor antagonists | |
| HK1246792A1 (en) | 6,7-dihydropyrazolo(1,5-a) pyrazin-4(5h)-one compounds | |
| IL234485A (en) | Imidazo [1,2-b] pyridazine-based compounds | |
| IL246028A0 (en) | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compounds, solid forms comprising same, compositions comprising same and processes for producing same | |
| PT2794611T (en) | Pyrazolo[1,5-a]pyrimidines as antiviral agents | |
| AP2015008867A0 (en) | 3,4-dihydroisquinolin-2(1h)-yl compounds | |
| HK1220201A1 (en) | Imidazo[1,2-a]pyridin-7-amines as imaging tools [12-a]-7- | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| HK1213559A1 (en) | Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists cb2 [23-d] | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| HUE043108T2 (en) | (5,6-dihydro)pyrimido[4,5-e]indolizines | |
| ZA201507151B (en) | Antiviral indolo[2,3-b]quinoxaline | |
| EP3227292A4 (en) | 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS | |
| AU2014904868A0 (en) | 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS | |
| GB201219129D0 (en) | Triazolo(4,5-d)pyrmindine compounds |